The Hippo pathway in the heart: pivotal roles in development, disease, and regeneration

J Wang, S Liu, T Heallen, JF Martin - Nature Reviews Cardiology, 2018 - nature.com
Abstract The Hippo–YAP (Yes-associated protein) pathway is an evolutionarily and
functionally conserved regulator of organ size and growth with crucial roles in cell …

The oncogenic roles and clinical implications of YAP/TAZ in breast cancer

J Luo, H Zou, Y Guo, T Tong, Y Chen, Y **ao… - British Journal of …, 2023 - nature.com
Breast cancer (BC) is the most commonly diagnosed form of cancer and a leading cause of
cancer-related deaths among women worldwide. Yes-associated protein (YAP) and …

The roles and regulation of the KLF5 transcription factor in cancers

Y Luo, C Chen - Cancer science, 2021 - Wiley Online Library
Krüppel‐like factor 5 (KLF5) is a member of the KLF family. Recent studies have suggested
that KLF5 regulates the expression of a large number of new target genes and participates …

[HTML][HTML] YAP/TAZ activation as a target for treating metastatic cancer

JSA Warren, Y **ao, JM Lamar - Cancers, 2018 - mdpi.com
Yes-Associated Protein (YAP) and Transcriptional Co-activator with PDZ-binding Motif (TAZ)
have both emerged as important drivers of cancer progression and metastasis. YAP and …

BAP1 promotes breast cancer cell proliferation and metastasis by deubiquitinating KLF5

J Qin, Z Zhou, W Chen, C Wang, H Zhang, G Ge… - Nature …, 2015 - nature.com
The transcription factor KLF5 is highly expressed in basal-like breast cancer and promotes
breast cancer cell proliferation, survival, migration and tumour growth. Here we show that, in …

WWP1 E3 ligase at the crossroads of health and disease

A Behera, ABM Reddy - Cell Death & Disease, 2023 - nature.com
The E3 ubiquitin ligase WWP1 (WW Domain-containing E3 Ubiquitin Protein Ligase 1) is a
member of the HECT (Homologous to the E6-associated protein Carboxyl Terminus) E3 …

Inhibition of autophagy as a new means of improving chemotherapy efficiency in high-LC3B triple-negative breast cancers

S Lefort, C Joffre, Y Kieffer, AM Givel, B Bourachot… - Autophagy, 2014 - Taylor & Francis
The triple-negative breast cancer (TN BC) subtype is the most aggressive form of invasive
BC. Despite intensive efforts to improve BC treatments, patients with TN BC continue to …

Metformin suppresses triple-negative breast cancer stem cells by targeting KLF5 for degradation

P Shi, W Liu, H Wang, F Li, H Zhang, Y Wu, Y Kong… - Cell discovery, 2017 - nature.com
Out of the breast cancer subtypes, triple-negative breast cancer (TNBC) has the poorest
prognosis without effective targeted therapies. Metformin, a first-line drug for type 2 diabetes …

New insights into KLFs and SOXs in cancer pathogenesis, stemness, and therapy

L Zeng, Y Zhu, CS Moreno, Y Wan - Seminars in cancer biology, 2023 - Elsevier
Despite the development of cancer therapies, the success of most treatments has been
impeded by drug resistance. The crucial role of tumor cell plasticity has emerged recently in …

Targeting the KLF5-EphA2 axis can restrain cancer stemness and overcome chemoresistance in basal-like breast cancer

P Zhao, J Sun, X Huang, X Zhang, X Liu… - International …, 2023 - pmc.ncbi.nlm.nih.gov
Ephrin type-A receptor 2 (EphA2) is a member of the tyrosine receptor kinases, a family of
membrane proteins recognized as potential anticancer targets. EphA2 highly expressed in a …